Results 211 to 220 of about 7,581 (239)

Ceftolozane–Tazobactam

Reactions Weekly
Stephanie J. Phelps, Tracy M. Hagemann, Kelley R. Lee   +2 more
  +4 more sources

Ceftolozane/tazobactam/ganciclovir

Reactions Weekly, 2021
openaire   +1 more source

Ceftazidime/ceftolozane/tazobactam

Reactions Weekly, 2021
openaire   +1 more source

Ceftolozane/tazobactam

Reactions Weekly, 2017
openaire   +2 more sources

Ceftolozane/tazobactam for difficult-to-treat Pseudomonas aeruginosa infections: A systematic review of its efficacy and safety for off-label indications

International Journal of Antimicrobial Agents, 2020
Alberto Enrico Maraolo, Maria Mazzitelli, Enrico Maria Trecarichi   +2 more
exaly  

Amikacin/ceftolozane/tazobactam/gentamicin

Reactions Weekly, 2022
openaire   +1 more source

Ceftolozane–tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial

Lancet Infectious Diseases, The, 2019
Marin H Kollef, Alvaro Rea-Neto, Nobuaki Shime   +2 more
exaly  

Emergence of Ceftolozane-Tazobactam-Resistant Pseudomonas aeruginosa during Treatment Is Mediated by a Single AmpC Structural Mutation

Antimicrobial Agents and Chemotherapy, 2017
Shawn H Macvane, Ruchi Pandey, Liang Chen   +2 more
exaly  

Can ceftolozane–tazobactam treat nosocomial pneumonia?

The Lancet Infectious Diseases, 2019
Andre C, Kalil, Alexandre P, Zavascki
openaire   +2 more sources

Ceftolozane-Tazobactam Activity against Pseudomonas aeruginosa Clinical Isolates from U.S. Hospitals: Report from the PACTS Antimicrobial Surveillance Program, 2012 to 2015

Antimicrobial Agents and Chemotherapy, 2017
Dee Shortridge, Mariana Castanheira
exaly